Skip to content
WellcomeY9C 100

Drawing based on the label description. No photo yet.

Wellcome Y9C 100 pill

Pill with imprint Wellcome Y9C 100 is white, capsule, 16 mm and has been identified as Zidovudine 100 mg. It is used for HIV. It is supplied by Viiv Healthcare Company.

Zidovudine 100 mg

Imprint
Wellcome Y9C 100
Strength
100 mg
Used for
HIV
Color
White
Shape
Capsule / oblong
Size
16 mm
Score
No score line
Form
Capsule
Manufacturer
Viiv Healthcare Company
Drug class
HIV medicine
NDC
49702-211, 49702-211-20

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Zidovudine pills and guides

What is Zidovudine used for?

Zidovudine is used for HIV.

Medicine type
HIV medicine
Official uses from the US prescribing label

Treatment of HIV-1

Zidovudine tablets, a nucleoside reverse transcriptase inhibitor, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Prevention of Maternal-Fetal HIV-1 Transmission

Zidovudine tablets are indicated for the prevention of maternal-fetal HIV-1 transmission. The indication is based on a dosing regimen that included 3 components: 1. antepartum therapy of HIV-1-infected mothers 2. intrapartum therapy of HIV-1-infected mothers 3. post-partum therapy of HIV-1-exposed neonate

Points to consider prior to initiating zidovudine in pregnant women for the prevention of maternal-fetal HIV-1 transmission include:

• In most cases, zidovudine for prevention of maternal-fetal HIV-1 transmission should be given in combination with other antiretroviral drugs.

• Prevention of HIV-1 transmission in women who have received zidovudine for a prolonged period before pregnancy has not been evaluated.

• Because the fetus is most susceptible to the potential teratogenic effects of drugs during the first 10 weeks of gestation and the risks of therapy with zidovudine during that period are not fully known, women in the first trimester of pregnancy who do not require immediate initiation of antiretroviral therapy for their own health may consider delaying use; this indication is based on use after 14 weeks' gestation.

From the FDA-approved label on DailyMed (published Jan 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows Wellcome Y9C 100. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, capsule, 16 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Retrovir.

Ingredients

Active: Zidovudine

Inactive: Starch, Corn, Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate Type A Potato, Ferrosoferric Oxide, Dimethicone, Unspecified, Gelatin, Unspecified, Shellac, Soybean Lecithin, Titanium Dioxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Zidovudine pills